tiprankstipranks
Trending News
More News >
Sapiens International (SPNS)
NASDAQ:SPNS
Advertisement

Sapiens (SPNS) AI Stock Analysis

Compare
242 Followers

Top Page

SP

Sapiens

(NASDAQ:SPNS)

Rating:80Outperform
Price Target:
$34.00
▲(13.14%Upside)
Sapiens International Corporation demonstrates solid financial health with consistent revenue and profitability growth. The technical indicators support a bullish outlook. The earnings call highlights strategic acquisitions and increased recurring revenue, though currency impacts and acquisition-related losses pose challenges. The valuation is fair, with a moderate P/E ratio and a modest dividend yield.
Positive Factors
Market Opportunity
The APAC region represents a significant market opportunity for Sapiens with increasing adoption of cloud-based solutions by insurers.
Revenue Growth
Recent acquisitions of Candela and AdvantageGo contributed to revenue guidance being raised by $20 million at the midpoint.
Strategic Acquisitions
The acquisition aligns with Sapiens’ strategic focus as a core system vendor to the global P&C insurance economy, enhancing its offerings for the London specialty market and supporting expansion into APAC and North America.
Negative Factors
FX Headwinds
FX headwinds weighed on the top line, impacting growth.
Margin Impact
Acquisitions will cause a -170bps margin impact in FY25.
Profitability
The company is currently operating at a reported loss, which creates a slight near-term drag to profitability.

Sapiens (SPNS) vs. SPDR S&P 500 ETF (SPY)

Sapiens Business Overview & Revenue Model

Company DescriptionSapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, the European Union, the United Kingdom, Israel, and internationally. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. It also provides Sapiens DigitalSuite for customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens ReinsuranceMaster and Sapiens ReinsurancePro reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, and Sapiens ClaimsGo for workers' compensation. In addition, the company offers financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Further, it provides tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. The company markets and sells its products and services through direct and partner sales. Sapiens International Corporation N.V. was founded in 1982 and is headquartered in Holon, Israel.
How the Company Makes MoneySapiens generates revenue primarily through the sale of software licenses and related services to insurance companies. Their business model includes recurring revenue from long-term contracts for software maintenance, support services, and cloud-based subscription offerings. Additionally, Sapiens earns income through professional services such as implementation, consulting, and training, which help clients integrate and optimize their software solutions. The company's strategic partnerships with technology and consulting firms further expand their market reach and enhance their service offerings, contributing significantly to their revenue streams.

Sapiens Earnings Call Summary

Earnings Call Date:May 08, 2025
(Q1-2025)
|
% Change Since: 3.41%|
Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strategic acquisitions and growth in recurring revenue and gross margin. However, challenges such as currency impacts, a decline in European revenue, and loss-making acquisitions were also noted. The positive aspects slightly outweigh the negative ones, with strategic acquisitions positioning the company for future growth.
Q1-2025 Updates
Positive Updates
Strategic Acquisitions
Sapiens International Corporation announced the acquisition of Candela, a leading intelligent automation company in the APAC market, and Advantage Go, a commercial insurance software provider. These acquisitions enhance Sapiens' capabilities in life and P&C segments, expanding their footprint in key markets like APAC and the London specialty market.
Revenue Growth
Revenue for Q1 2025 totaled $136 million, an increase of 1.4% compared to Q1 2024. On a constant currency basis, revenue would have been $2 million higher.
Increase in Recurring Revenue
Annualized recurring revenue (ARR) for Q1 2025 totaled $187 million, reflecting an 11.8% increase from Q1 2024. Recurring revenue represents 79% of total revenue, up from 70% in Q1 2024.
Improvement in Gross Margin
Gross margin increased to 46.3% in Q1 2025 from 45.4% in Q1 2024, representing an increase of 90 basis points.
Positive Cash Flow and Dividends
Adjusted free cash flow for Q1 2025 was $23 million, up from $17 million in Q1 2024. The company also paid a $16.8 million dividend for the second half of 2024 and declared a special dividend of $20.1 million.
Negative Updates
Currency Impact on Revenue
There was a negative currency impact on revenue for Q1 2025 compared to Q1 2024, which would have been $2 million higher on a constant currency basis.
Decline in European Revenue
Revenue in Europe decreased by 1.8% compared to last year. On a constant currency basis, revenue in Europe would have been 0.6% higher.
Loss-Making Acquisitions
The Advantage Go acquisition is expected to remain loss-making throughout the year, impacting overall profitability despite strategic benefits.
Company Guidance
During the Sapiens International Corporation's 2025 First Quarter Financial Results Call, the company provided updated guidance for the fiscal year. Revenue for Q1 2025 was $136 million, marking a 1.4% increase from Q1 2024, despite a $2 million negative currency impact. North American revenue grew by 3.1% to $57 million, while European revenue decreased by 1.8% to $67 million, with constant currency adjustments indicating a 0.6% increase. The Rest of the World, including South Africa and APAC, saw a 13.4% increase to $12 million. The annualized recurring revenue (ARR) rose 11.8% to $187 million. Sapiens raised its non-GAAP revenue guidance to a range of $574 million to $578 million, representing a 6% growth at the midpoint. The operating profit guidance was adjusted to $94 million to $96 million, with an 18% operating margin target. The company anticipates the acquisitions of Candela and Advantage Go to contribute around $21 million to revenue at the midpoint, with a $5 million negative impact on profit due to integration complexities. Despite these short-term impacts, Sapiens expects robust growth and enhanced profitability in the future, aiming for mid to high single-digit revenue growth in 2026.

Sapiens Financial Statement Overview

Summary
Sapiens exhibits strong financial performance with consistent revenue growth, high profitability margins, and stable cash flows. The balance sheet shows effective debt management and robust equity, supporting long-term growth and sustainability.
Income Statement
85
Very Positive
Sapiens demonstrated strong income statement metrics with a consistent revenue growth trajectory, highlighted by a TTM revenue of $544.2M, up from $542.4M in 2024. The company's gross profit margin stands at 44.6%, with a net profit margin of 13.4% in TTM, indicating solid profitability. EBIT and EBITDA margins of 15.9% and 19.4% respectively, further underscore operational efficiency. The revenue growth rate from 2023 to 2024 was 5.4%, showcasing a steady upward trend.
Balance Sheet
80
Positive
The balance sheet reflects a strong equity position with a stockholders' equity of $460.6M and an equity ratio of 64.5% in TTM, indicating financial stability. The debt-to-equity ratio has improved to 0.09 in TTM, down from 0.13 in 2024, showcasing effective leverage management. Additionally, return on equity (ROE) remains robust at 15.8%, suggesting efficient use of equity capital.
Cash Flow
78
Positive
Sapiens has demonstrated healthy cash flow metrics, with a TTM free cash flow of $78.8M and a free cash flow to net income ratio of 1.08, indicating strong cash generation relative to earnings. The operating cash flow to net income ratio is 1.22, reflecting efficient cash operations. The free cash flow growth rate from 2023 to 2024 was 13.1%, suggesting a positive trend in cash flow generation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue544.24M542.38M514.58M474.74M461.04M382.90M
Gross Profit242.78M238.11M219.59M200.16M187.84M155.97M
EBITDA105.81M105.92M94.86M83.52M84.12M63.62M
Net Income72.75M72.18M62.44M52.59M47.17M33.77M
Balance Sheet
Total Assets713.98M691.71M689.62M666.75M714.99M714.16M
Cash, Cash Equivalents and Short-Term Investments205.86M216.19M202.12M180.28M210.24M182.56M
Total Debt43.20M63.75M87.05M116.57M148.36M177.17M
Total Liabilities239.64M212.08M239.68M265.49M306.27M330.47M
Stockholders Equity460.59M479.63M447.27M400.50M406.55M381.69M
Cash Flow
Free Cash Flow78.77M79.35M70.16M34.73M68.69M47.01M
Operating Cash Flow88.87M82.22M79.42M43.78M80.54M58.26M
Investing Cash Flow-9.85M13.41M-72.78M-12.44M125.00K-114.60M
Financing Cash Flow-53.18M-56.28M-43.34M-58.38M-39.96M156.51M

Sapiens Technical Analysis

Technical Analysis Sentiment
Positive
Last Price30.05
Price Trends
50DMA
28.95
Positive
100DMA
27.83
Positive
200DMA
28.59
Positive
Market Momentum
MACD
0.33
Negative
RSI
58.54
Neutral
STOCH
53.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SPNS, the sentiment is Positive. The current price of 30.05 is above the 20-day moving average (MA) of 29.50, above the 50-day MA of 28.95, and above the 200-day MA of 28.59, indicating a bullish trend. The MACD of 0.33 indicates Negative momentum. The RSI at 58.54 is Neutral, neither overbought nor oversold. The STOCH value of 53.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPNS.

Sapiens Risk Analysis

Sapiens disclosed 39 risk factors in its most recent earnings report. Sapiens reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Sapiens Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$1.68B23.2016.09%1.85%3.84%10.25%
68
Neutral
¥228.97B14.577.50%3.81%9.28%6.70%
SPSPT
64
Neutral
$1.10B-36.95%17.79%16.49%
63
Neutral
$1.32B191.612.81%22.75%-47.45%
63
Neutral
$1.65B-32.87%8.56%-4.21%
60
Neutral
$1.25B-6.49%5.15%28.27%
56
Neutral
$1.39B527.454.45%15.51%-55.49%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SPNS
Sapiens
30.05
-9.03
-23.11%
SPT
Sprout Social
18.96
-18.29
-49.10%
SEMR
SEMrush Holdings
8.91
-5.43
-37.87%
MLNK
MeridianLink
16.21
-7.34
-31.17%
AMPL
Amplitude
12.59
4.26
51.14%
ENFN
Enfusion
10.76
1.56
16.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 11, 2025